Skip to main content
. 2018;19(2):337–342. doi: 10.22034/APJCP.2018.19.2.337

Table 3.

Comparison of Demographic, Clinical, Hematological and Virological Markers Parameters among Patients with Acute Myeloid Leukemia According to Presence of Parvovirus B19 Infection

Parameter Recent Infection Past Infection group No infection p value
(n=28) (n=3) (n=5)
Sex
 Male 14 (50%) 3 (100%) 3 (60%) 0.4
 Female 10 (35.7%) 0 (0%) 2 (40%)
Age 6.8±3.4 8.00±3.00 5.8±3.7 0.7
Rash 17 (60.7%) 1 (33.3%) 3 (60%) 0.8
Fever 20 (71.4%) 3 (100%) 3 (60%) 0.8
Hepatosplenomegaly 24 (85.7%) 3 (100%) 3 (60%) 0.5
Lymphadenopathy 20 (71.4%) 3 (100) 3 (60%) 0.5
Hemoglobin g/dl 4.2±0.1 6.3±2.2 7.2±1.5 0.01
RBCs x 106/l 1.25±0.5 2.3±1.7 3.01±0.5 0.0001
WBC x 103/mm3 27.5±1.5 29.6±1.4 30.2±9.8 0.5
Lymphocytes x 103/mm3 19.50±9.50 9.00±1.50 10.00±1.00 0.0003
Neutrophils x 103/mm3 5.40±1.50 10.20±120 18.5±10.50 0.02
Platelets x 103/mm3 78.28±7.2 105.00±50.000 123.2±60.1 0.01
IgM 12 (42.8%) 0 (0%) 0 (0%) 0.04
PCR 16 (57.1%) 0 (0%) 0 (0%) 0.04
IgG 8 (28.6%) 3 (100%) 0 (0%) 0.7